Furthermore, chronic inflammation and oxidative stress contribute to the creation of a hypoxic tumour environment, which activates signalling pathways like MAPK/ERK and stabilises hypoxia-inducible factor-1 alpha (HIF-1α), further upregulating the expression of angiogenic factors. This evidence concerns the gene HIF1A and neoplasm.